Multiple sclerosis after allergen-specific immunotherapy and influenza vaccination

European Neurology

Volumn 50, Issue 4, 2003, Pages 248-249

  Nakajima, Hideto ^a   Ohtsuka, Sizue ^a   Nishina, Takuya ^a   Sugino, Masakazu ^a   Kimura, Fumiharu ^a   Hanafusa, Toshiaki ^a   Ikemoto, Toshiyuki ^a   Shimizu, Akira ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ADULT; ANAMNESIS; ARTICLE; BACKACHE; CASE REPORT; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOTHERAPY; INFLUENZA VACCINATION; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE; PRIORITY JOURNAL; VISUAL IMPAIRMENT;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; DESENSITIZATION, IMMUNOLOGIC; FEMALE; FLOW CYTOMETRY; HUMANS; INFLUENZA VACCINES; MULTIPLE SCLEROSIS; RECEPTORS, CHEMOKINE; RHINITIS; TIME FACTORS; VACCINATION;

EID: 0344197679     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073867     Document Type: Article

References (11)

1. Miller AE, Morgante LA, Buchwald LY, Nutile SM, Coyle PK, Krupp LB, Doscher CA, Lublin FD, Knobler RL, Trantas F, Kelley L, Smith CR, La-Rocca N, Lopez S: A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis. Neurology 1997;48:312-314.
2. Confavreux C, Suissa S, Saddier P, Bourdes V, Vukusic S: Vaccinations and the risk of relapse in multiple sclerosis. N Engl J Med 2001;344:319-326.
3. Rutschmann OT, McCrory DC, Matchar DB: Immunization and MS: A summary of published evidence and recommendations. Neurology 2002;59:1837-1843.
4. Moriabadi NF, Niewiesk S, Kruse N, Jung S, Weissbrich B, ter Meulen V, Toyka KV, Rieckmann P: Influenza vaccination in MS: Absence of T-cell response against white matter proteins. Neurology 2001;56:938-943.
5. Salvetti M, Pisani A, Bastianello S, Millefiorini E, Buttinelli C, Pozzilli C: Clinical and MRI assessment of disease activity in patients with multiple sclerosis after influenza vaccination. J Neurol 1995;242:143-146.
6. Misu T, Onodera H, Fujihara K, Matsushima K, Yoshie O, Okita N, Takase S, Itoyama Y: Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: Imbalance of Th1/Th2-associated chemokine signaling. J Neuroimmunol 2001;114:207-212.
7. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, Sozzani S, Allavena P, Gray PA, Mantovani A, Sinigaglia F: Differential expression of chemokine receptors and chemotactic responsiveness of type 1 helper cells (Th1s) and Th2s. J Exp Med 1998;187:129-134.
8. Kim CH, Rott L, Kunkel EJ, Genovese MC, Andrew DP, Wu L, Butcher EC: Rules of chemokine receptor association with T cell polarization in vivo. J Clin Invest 2001;108:1331-1339.
9. Calabresi PA, Tranquill LR, McFarland HF, Cowan EP: Cytokine gene expression in cells derived from CSF of multiple sclerosis patients. J Neuroimmunol 1998;89:198-205.
10. Jutel M, Pichler WJ, Skrbic D, Urwyler A, Dahinden C, Muller UR: Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen-stimulated T-cell cultures. J Immunol 1995;154:4187-4194.
11. Ebner C, Siemann U, Bohle B, Willheim M, Wiedermann U, Schenk S, Klotz F, Ebner H, Kraft D, Scheiner O: Immunological changes during specific immunotherapy of grass-pollen allergy: Reduced lymphoproliferative responses to allergen and shift from Th2 to Th1 in T-cell clones specific for Phl p 1, a major grass-pollen allergen. Clin Exp Allergy 1997;27:1007-1015.